Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
83.36 M
About BIOCARTIS
Sector
Industry
CEO
John Roger Moody
Website
Headquarters
Mechelen
Founded
2014
ISIN
BE0974281132
FIGI
BBG008HBYKH9
Biocartis Group NV engages in the development of personalized medicine for patients around the world. It also focuses on developing and commercializing oncology tests. The company was founded by Philippe Renaud, Nader Donzel, and Rudi Pauwels in July 2007 and is headquartered in Mechelen, Belgium.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of BCART is 0.290 EUR — it has increased by 1.05% in the past 24 hours. Watch BIOCARTIS stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on EURONEXT exchange BIOCARTIS stocks are traded under the ticker BCART.
BCART reached its all-time high on Jan 15, 2018 with the price of 13.084 EUR, and its all-time low was 0.285 EUR and was reached on Sep 19, 2023. View more price dynamics on BCART chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
BCART stock is 2.09% volatile and has beta coefficient of 0.00. Track BIOCARTIS stock price on the chart and check out the list of the most volatile stocks — is BIOCARTIS there?
Today BIOCARTIS has the market capitalization of 27.24 M, it has decreased by −3.37% over the last week.
Yes, you can track BIOCARTIS financials in yearly and quarterly reports right on TradingView.
BIOCARTIS is going to release the next earnings report on Feb 27, 2025. Keep track of upcoming events with our Earnings Calendar.
No, BCART doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, BCART shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIOCARTIS stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BIOCARTIS technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BIOCARTIS stock shows the sell signal. See more of BIOCARTIS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.